[The 2026 version of the National Basic Medical Insurance Drug Catalog is released 107 new drugs added] November 14th, the National Medical Insurance Administration and the Ministry of Human Resources and Social Security today (14th) released the "National Basic Medical Insurance, Maternity Insurance and Work-related Injury Insurance Drug Catalog" and the "Commercial Health Insurance Innovative Drug Catalog" (2026). This is the ninth adjustment of the National Basic Medical Insurance Drug Catalog since the establishment of the National Medical Insurance Administration. A total of 107 new drugs were added in this adjustment, 51 of which are Category 1 innovative drugs, setting a new record high. This time the national basic medical insurance drug catalog is adjusted, the new varieties cover many clinically urgent treatment fields such as tumors, rare diseases, chronic diseases, mental diseases, etc. At the same time, 34 drugs with limited clinical value, better alternatives, or missing information on the instructions and unavailability were removed from the catalog. After comprehensive transfer-in, transfer-out and dosage form merging, the total number of drugs in the 2026 edition of the National Basic Medical Insurance Drug List reaches 3,331.